BPC-157 (Body Protection Compound) Often called the healing peptide, BPC-157 has been studied for its potential to: Promote repair of soft tissue Improve blood flow to the healing site Reduce micro-inflammation Support healthy recovery of muscles, tendons, and skin For our patients, this may translate to smoother healing of the incision site and improved overall comfort in the early postoperative period
In the liver, adequate Glutathione levels enable efficient toxin removal
These include: Infection Soreness at the injection site (usually short-lived) Diabetic patients may see transient increases in their blood glucose with corticosteroid injections Patients with poorly controlled blood pressure may see a transient increase in their blood pressure Changes in skin pigmentation around the injection site (can be seen with corticosteroid injections, particularly if near the skin surface) Post-injection flare, a short-lived increase in pain and inflammation occurring shortly after injection caused by a reaction to the injected material Pseudo-sepsis, a rare allergic type reaction to viscosupplementation that can result in significant pain and swelling which can, at times, mimic infection
Emerging incretin-related therapies are under investigation for obesity and metabolic disorders including type 2 diabetes
The contributions of each substitution are discussed in detail and mainly summarized in Table 1
Clinical literature frequently cites that the systemic bioavailability of standard oral glutathione is a dismal 1% to 5%, meaning the vast majority of the supplement is destroyed before it ever reaches your bloodstream